PFIZER — Pfizer Income Statement
0.000.00%
Last trade - 00:00
- IN₹188.95bn
- IN₹171.02bn
- IN₹24.25bn
- 96
- 13
- 44
- 50
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20,815 | 21,517 | 22,386 | 26,110 | 24,248 |
Cost of Revenue | |||||
Gross Profit | 12,650 | 13,000 | 13,798 | 16,023 | 14,971 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15,468 | 16,396 | 16,252 | 18,794 | 16,803 |
Operating Profit | 5,347 | 5,121 | 6,133 | 7,316 | 7,444 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6,599 | 6,425 | 6,687 | 7,729 | 8,240 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,291 | 5,091 | 4,976 | 6,126 | 6,239 |
Net Income Before Extraordinary Items | |||||
Net Income | 4,291 | 5,091 | 4,976 | 6,126 | 6,239 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4,291 | 5,091 | 4,976 | 6,126 | 6,239 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 89.7 | 106 | 108 | 133 | 131 |
Dividends per Share | |||||
Special Dividends per Share |